The Future of Duchenne Muscular Dystrophy Treatment: Expert Insights on Gene Therapy

Inflammation an Under-Explored Topic in DMD Gene Therapy, Report Argues

In an opinion article, investigators argue that gene therapies may not achieve their full potential if the innate inflammation in Duchenne muscular dystrophy is not effectively managed.

The Future of Duchenne Muscular Dystrophy Treatment: Expert Insights on Gene Therapy

A panelist discusses how ongoing research into next-generation DMD therapies aims to improve delivery methods, develop better vectors that can carry larger dystrophin genes, and determine optimal treatment timing, with evidence suggesting earlier intervention may be more effective.